|
Volumn 28, Issue 8, 2006, Pages 434-443
|
Equine laminitis 1. Management in the acute stage
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACEPROMAZINE;
ACETYLSALICYLIC ACID;
ANALGESIC AGENT;
ANTICOAGULANT AGENT;
ANTIOXIDANT;
BUTORPHANOL;
CORTICOSTEROID;
CYCLOOXYGENASE 1 INHIBITOR;
CYCLOOXYGENASE 2 INHIBITOR;
DETOMIDINE;
DIMETHYL SULFOXIDE;
ENDOTOXIN;
FENTANYL;
FLUNIXIN MEGLUMINE;
GLUCOCORTICOID;
GLYCERYL TRINITRATE;
HEPARIN;
ISOXSUPRINE;
KETAMINE;
KETOPROFEN;
LIDOCAINE;
MELOXICAM;
MORPHINE;
NONSTEROID ANTIINFLAMMATORY AGENT;
PENTOXIFYLLINE;
PHENYLBUTAZONE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
SUXIBUZONE;
VASODILATOR AGENT;
ANALGESIA;
CLINICAL FEATURE;
CRYOTHERAPY;
DISEASE COURSE;
DRUG INFUSION;
ENDOCRINE DISEASE;
ENDOTOXEMIA;
FECES IMPACTION;
GASTROINTESTINAL TOXICITY;
HOOF AND CLAW;
HORSE DISEASE;
LIMB DISEASE;
MICROTHROMBUS;
NEPHROTOXICITY;
NONHUMAN;
ORTHOPEDIC EQUIPMENT;
PALLIATIVE THERAPY;
PATHOGENESIS;
PATHOPHYSIOLOGY;
REVIEW;
RISK FACTOR;
SPLINTING;
EQUIDAE;
HORDEUM VULGARE SUBSP. VULGARE;
JUGLANS NIGRA;
|
EID: 33748847477
PISSN: 0263841X
EISSN: 20427689
Source Type: Journal
DOI: 10.1136/inpract.28.8.434 Document Type: Review |
Times cited : (8)
|
References (5)
|